Boc-(R)-3-Amino-4-(2,4,5-Trifluoro-Phenyl)-Butyric Acid CAS 486460-00-8 Maʻemaʻe ≥99.5% (HPLC) Sitagliptin Phosphate Monohydrate Intermediate

ʻO ka wehewehe pōkole:

Boc-(R)-3-Amino-4-(2,4,5-Trifluoro-Phenyl)-Butyric Acid

CAS: 486460-00-8

Maʻemaʻe: ≥99.5% (HPLC)

ʻAno: Keʻokeʻo a i ʻole ka pauka keʻokeʻo

ʻO ka waena o Sitagliptin Phosphate Monohydrate (CAS: 654671-77-9) no ka mālama ʻana i ka maʻi diabetes type II.

ʻO ke kūlana kiʻekiʻe, ka hana kālepa

E-Mail: alvin@ruifuchem.com


Huahana Huahana

Nā Huahana Pili

Huahana Huahana

wehewehe:

Na Waiwai Kemika:

Inoa Kimia Boc-(R)-3-Amino-4-(2,4,5-Trifluoro-Phenyl)-Butyric Acid
Nā huaʻōlelo like (R)-Sitagliptin N-Boc-Acid Impurity
Helu CAS 486460-00-8
Helu CAT RF-PI1192
Kūlana Kūʻai Ma ka waihona, ʻoi aku ka nui o ka hana a hiki i nā tona
ʻĀpana Molekala C15H18F3NO4
Kaumaha Molecular 333.31
Lae hehee 136.0~138.0 ℃
Brand Kemika Ruifu

Nā kikoʻī:

'ikamu Nā kikoʻī
Ka nana aku Keʻokeʻo a hiki i ka pauda keʻokeʻo
ʻIke ʻia e HPLC ʻO ka manawa paʻa o ka laʻana e kūlike me ka maʻamau kuhikuhi
Nalo ma ka maloo ≤0.50%
Lehu Sulphated ≤0.50%
Metala Kaumaha <20ppm
Isomer ≤0.50%
Na mea pili
haumia A ≤0.50%
ʻO nā mea haumia ʻē aʻe ≤0.50%
Huina paumaele ≤0.50%
Maemae ≥99.5% (HPLC)
Kūlana hoʻāʻo ʻOihana Kūlana
Hoʻohana Ka waena o Sitagliptin Phosphate Monohydrate (CAS: 654671-77-9)

Pūʻolo a me ka waiho ʻana:

Pūʻolo: ʻO ka ʻōmole, ʻeke ʻeke alumini, 25kg / pahu pahu pahu, a i ʻole e like me ka makemake o ka mea kūʻai aku.

Kūlana mālama:E mālama i loko o nā pahu i hoʻopaʻa ʻia ma kahi maloʻo a maloʻo;E pale i ka malamalama a me ka wai.

Pono:

1

FAQ:

Noi:

ʻO Boc-(R)-3-Amino-4-(2,4,5-Trifluoro-Phenyl)-Butyric Acid (CAS: 486460-00-8) he mea koʻikoʻi ia no ka hoʻomākaukau ʻana i ka sitagliptin.ʻO Sitagliptinphosphate ka dipeptidase -IV (DPP-4) inhibitor mua i ʻae ʻia e FDA ma 2006. Hoʻohana ʻia ia no ka mālama ʻana i ka maʻi diabetes type II.Loaʻa ka hopena hypoglycemic inā hoʻohana wale ʻia a i hui pū ʻia me ka metformin a me ka pioglitazone, a palekana ke lawe ʻia, ʻae ʻia, me ka liʻiliʻi o nā hopena ʻino.I ʻAukake 2009, ua ʻae ʻia ka lāʻau lapaʻau e ka European Union ma ke ʻano he lāʻau lapaʻau mua no ka mālama ʻana i ka maʻi diabetes type 2.Ma hope o 2011, ua ʻae kekahi ma hope o nā ʻāina i ka hui pū ʻana o ka sitagliptin phosphate a me alpha glycosidase inhibitors a i ʻole insulin.ʻO Sitagliptin phosphate ka mea mua i ʻae ʻia e ka FDA i ka dipeptidyl peptidase-IV inhibitor e hoʻohana ʻia i ka mālama ʻana i ka maʻi diabetes type 2 ma kahi mamao, ma lalo o ka inoa kālepa Januvia.

E kākau i kāu leka ma aneʻi a hoʻouna mai iā mākou